Table 5.
Outcome variables of the included studies
Study | Sample groups | VAS scale (1–10) Mean ± SD | Maximum mouth opening (mm) Mean ± SD | ||
---|---|---|---|---|---|
Baseline | Outcome | Baseline | Outcome | ||
1. Diracoglu et al. [18] | Arthrocentesis- | 6.26 ± 2.3 | 1.51 ± 1.82 | 29.2 ± 7 | 37.89 ± 6.5 |
Non-invasive therapies- | 5.66 ± 2.4 | 4.39 ± 2.31 | 29.89 ± 4.8 | 35.54 ± 6.41 | |
2. Hosgor et al. [16] | Arthrocentesis- | 7.40 ± 0.30 | 2.60 ± 0.73 | 28.40 ± 2.11 | 39.00 ± 2.60 |
Non-invasive therapies- | 7.00 ± 0.63 | 3.20 ± 1.12 | 35.70 ± 2.75 | 43.00 ± 1.75 | |
3. Tatli et al. [15] | Arthrocentesis- | 6.6 ± 2.2 | 0.3 ± 0.8 | 28.5 ± 3.5 | 42.2 ± 4.5 |
Non-invasive therapies- | 6.8 ± 1.5 | 2.0 ± 2.4 | 29.2 ± 2.9 | 38.1 ± 4.1 | |
VAS scale (1–100) | Maximum mouth opening (mm) | ||||
4. Malekzadeh et al. [19] | Arthrocentesis- | 57.7 ± 17.8 | 10 ± 6.3 | 27.2 ± 2.8 | 42.7 ± 6.1 |
Non-invasive therapies- | 49.5 ± 30 | 11 ± 17.1 | 28.4 ± 5.0 | 46.3 ± 7.2 | |
5. Ohnuki et al. [17] | Arthrocentesis- | 55 ± 23 | 2.2 ± 3.7 | 30.0 ± 5.9 | 44.6 ± 3.0 |
Non-invasive therapies- | 53 ± 22 | 2.7 ± 3.4 | 35.1 ± 6.6 | 43.8 ± 3.7 |